• Macro Notes
  • Posts
  • Trade Tensions Ease, but Not All Risks Are Gone

Trade Tensions Ease, but Not All Risks Are Gone

A flurry of trade deals just shifted the macro narrative. The U.S. and Japan avoided a tariff spike, and Europe followed suit. The market is celebrating, but there’s more under the surface. Here’s what investors need to know.

The White House has pivoted from threats to deals, setting a new 15% tariff standard on key U.S. trading partners.

Markets welcomed the shift. The IMF raised its global growth forecast. Stocks rallied. But underneath the optimism, uncertainty still lingers.

The U.S.–Japan trade agreement replaced a threatened 25% tariff with a 15% rate across most goods, including cars. Toyota shares soared 14% on the news.

Japan also committed to a $550 billion investment package in the U.S., easing fears of deeper friction.

Days later, the European Union agreed to similar terms, pledging to buy $750 billion in U.S. energy and invest an additional $600 billion. The EU will see 15% base tariffs instead of the 30% initially floated.

These deals mark a turning point in the tariff saga. But with unresolved talks still ongoing with China, Canada, and Mexico, this isn’t over. A truce with China currently expires on August 12.

The administration is threatening to hike Canadian tariffs to 35% by the end of this week (on non-USMCA goods). Meanwhile, some sectors like steel and pharmaceuticals remain in limbo.

Still, the deals with Japan and Europe reduce downside risk. Both regions avoided worst-case scenarios, and global equity markets are responding.

The Nikkei jumped 3.5%. The S&P 500 and STOXX Europe 600 notched fresh year-to-date highs.

The IMF now expects 2.7% global GDP growth in 2025, up from 2.4% in April. Forecasts for the U.S., China, and Europe all improved.

But the optimism rests on a fragile assumption, that this round of tariff talks holds and no new shocks emerge. We’ve repeatedly seen talks fall apart, and the market is pricing in perfection at this point.

Double Shot (Sponsored)

How would it feel to double your money by this time next year?

From thousands of stocks, only 5 have emerged with the best chance to gain +100% or more in the months ahead.

You can see all five of these tickers — absolutely free.

Just download the newly released 5 Stocks Set to Double special report from Zacks.

While we can’t guarantee future performance, previous editions of this report have delivered gains of +175%, +498%, and even +673¹.

The newest picks could be just as profitable.

Act fast — this opportunity ends at MIDNIGHT TONIGHT.

Download the report now, absolutely free

*Results may not represent all stock picks and may reflect partially closed positions. Investing involves risk, and past performance does not guarantee future results. This is not financial advice.

Stay Up to Speed on Macro News!

We now send our macro-focused news via text, so you’re never far from the latest market-moving action.

Economic Impacts

Deals Reduce Tail Risk, but the Clock Is Still Ticking

The 15% tariff agreements with Japan and the European Union have immediate implications for trade flows, capital investment, and inflation expectations, but the economic landscape remains uneven.

On the positive side, the IMF cited easing trade tensions as a key reason for upgrading global growth projections.

U.S. exports to Japan and the EU are now expected to rise, supported by large-scale investment pledges and preferential treatment for sectors like energy and aerospace.

Early data show a rebound in durable goods orders and stronger-than-expected retail and mortgage activity, suggesting consumer resilience remains intact for now.

However, the economic benefits are asymmetrical. While Japanese automakers and U.S. energy firms stand to gain, other sectors remain vulnerable. The pharmaceutical and steel industries still face uncertainty, with sector-specific levies unresolved.

Europe's pharma exports to the U.S. exceeded $127 billion last year, and whether they’ll be subject to full tariffs remains a question.

The truce with China is also set to expire in mid-August. If no deal is reached, tariffs could spike back to the 145% peak briefly seen earlier this year.

Canada and Mexico remain under threat as well, with U.S. officials signaling potential hikes as early as this Friday.

Investment decisions are already being affected. Construction permits are falling. Small businesses cite higher input costs.

And while consumer prices have stabilized broadly, tariff-sensitive categories like toys and apparel showed price jumps in June, indicating early pass-through effects.

In short, two major deals are in place, but global trade stability is still a work in progress.

Climb (Sponsored)


The stock market is buzzing with opportunities, and I’ve got the insider scoop just for you.

I’ve handpicked the Top Seven Stocks for this quarter, offering you a clear roadmap for growth as the year progresses.

Here’s what makes this guide indispensable:

  1. High-Growth Sectors: Key industries poised to boom this summer.

  2. In-Depth Analysis: Simplified insights to make wise investment decisions.

  3. Expert Picks: Data-driven, not just guesses, for reliable potential.

  4. Profit-Boosting Opportunities: Position your portfolio for a strong finish in 2025.

This isn’t merely a list; it’s your chance to seize the market’s hottest opportunities before they pass you by.

Investor Takeaways

Two Big Deals Down, But the Playbook Isn’t Changing

Investors should welcome the recent U.S.–Japan and U.S.–EU trade agreements. They reduce uncertainty, support sentiment, and provide clarity on some of the world’s largest trading relationships. But this is not a green light to chase risk blindly.

These deals are best viewed as a ceiling, not a floor. Tariffs at 15% are still elevated compared to pre-2025 levels and could pressure margins in trade-heavy industries.

Moreover, the unresolved China situation and escalating rhetoric toward Canada, Mexico, and India mean that trade-driven volatility isn’t going away.

The opportunity lies in tilting toward sectors and companies that benefit from clarity and domestic insulation. U.S. firms with high exposure to Japan and the EU, particularly in energy, aerospace, and enterprise software, may see upside as bilateral investment ramps up.

Companies that have already localized supply chains or shifted production to less-targeted countries are also well-positioned.

Meanwhile, defensive sectors like utilities and healthcare continue to offer stability, especially as leadership rotates and equity markets digest the rapid move to new highs.

As always, don’t let momentum distract from macro signals, and keep one eye on the Aug. 1 and Aug. 12 deadlines.

Policy Edge (Sponsored)

While many are busy chasing the usual AI trends, a bigger opportunity is quietly brewing—and most are missing it.

Imagine a major shift in how and where AI is built, opening up incredible wealth opportunities for those in the know.

I’ve found 9 AI companies primed to lead this change.

These aren’t the tired “AI hype” stocks; they’re companies with real US operations, proven revenue growth, and deep AI integration.

I’ve put all the details in a FREE report: "Top 9 AI Stocks For This Month." 

Inside you’ll discover:

  •  A hidden chip maker set to power domestic AI manufacturing

  • A cloud provider ready for explosive growth due to relaxed regulations

  • A data analytics leader positioned to win government contracts

The smart money is watching—and once they move, these stocks could soar.

Don’t be the last to catch this wave.

Act fast - opportunity waits for no one!

Top Takeaways

The U.S. has secured 15% tariff agreements with Japan and the EU, easing fears of a global trade war
Investment flows from both regions are set to increase, supporting U.S. energy and manufacturing
Tariff-sensitive prices are already rising, hinting at cost pressures that could ripple into Q3 earnings
Deals with China, Canada, and Mexico are unresolved, with key deadlines still ahead
Uncertainty remains in pharma, autos, and steel, where sector-specific tariffs are still on the table

Top Picks

Thermo Fisher Scientific (NYSE: TMO)

$482.16 Last Close (-7.73% YTD)
As global trade clarity returns and pharmaceutical tariffs remain in limbo, Thermo Fisher stands out.

With its critical role in research and diagnostics, the company is insulated from many supply chain disruptions.

It’s also well-positioned to benefit if pharma reshoring accelerates, given its U.S. footprint and exposure to biotech capital spending.

Schneider National (NYSE: SNDR)

$25.27 Last Close (-13.25% YTD)
A leading logistics and trucking company, Schneider is set to benefit from the reshuffling of supply chains.

As tariffs shift sourcing decisions and spur nearshoring, demand for domestic transport capacity should rise.

Schneider’s strong balance sheet and exposure to intermodal shipping make it a quiet winner in a fragmented sector.

Oracle Corporation (NYSE: ORCL)

$249.98 Last Close (+50.56% YTD)
With Europe pledging $600 billion in new U.S. investment, enterprise software providers are in prime position.

Oracle’s cloud transition is accelerating, with exposure across energy, healthcare, and government sectors, all of which are expected to see funding flows.

Investors looking for large-cap tech with valuation support should keep this on their radar.

Enphase Energy (NASDAQ: ENPH)

$33.48 Last Close (-53.08% YTD)
A surprise winner from the U.S.–EU deal could be renewable energy. With Europe agreeing to buy $750 billion in U.S. energy, clean tech exporters like Enphase are in a stronger position.

The company’s solar microinverter products are gaining traction globally, and its margins benefit from reduced materials volatility and rising grid independence demand.

Stock to Buy

Corteva Inc. (NYSE: CTVA)

$72.88 Last Close (+29.36% YTD)
Corteva is a standout in the agriculture and seed technology space. As tariffs on Asian inputs drive a push for local resilience, U.S.-based agricultural firms could see renewed interest.

The EU's agreement to purchase more U.S. energy and materials may spill into food systems, where Corteva is already a key supplier.

The company combines strong R&D, broad adoption across U.S. farms, and a growing digital platform that improves yield efficiency.

With global food prices still elevated and weather volatility on the rise, Corteva’s crop protection and genetics business is becoming more valuable.

It also fits the current moment:

  • Limited exposure to global supply chain bottlenecks

  • Strong positioning for agricultural self-sufficiency themes

  • Trading at under 15x forward earnings with improving margins

  • Dividend growth and a clear capital allocation framework

In an environment where trade policy remains a wildcard, Corteva offers exposure to a sector with tailwinds that extend beyond tariff headlines.

That’s it for today’s edition—thanks for reading! Reply to this email with any feedback or let me know which macro trends or markets you’d like me to cover next.

Best Regards,
—Noah Zelvis
Macro Notes